CLINICAL_TRIALS trial_result · 2021-08-24

Clinical Trial Update: Safinamide for Multiple System Atrophy (MSA) [Phase 2]

Phase 2 trial update for safinamide in Multiple System Atrophy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Zambon SpA | Conditions: Multiple System Atrophy | Phase 2 | Status: COMPLETED | Results posted: 2021-08-24